Intuitive Surgical (1ISRG) Stock Forecast & Price Target

Compare

12 Followers

See the Price Targets and Ratings of:

All Analysts

Top Analysts

Premium

1ISRG Analyst Ratings

Moderate Buy

16 Buy

4 Hold

1 Sell

Based on 21 analysts giving stock ratings to

Intuitive

Surgical

in the past 3 months

TipRanks enables you to focus on the analyst rating consensus of all analysts or only the top performers in the past 3 months

1ISRG Stock 12 Month Forecast

Average Price Target

€512.36

▲(32.72% Upside)

Based on 21 Wall Street analysts offering 12 month price targets for Intuitive Surgical in the last 3 months. The average price target is €512.36 with a high forecast of €584.03 and a low forecast of €375.14. The average price target represents a 32.72% change from the last price of €386.05.

{"navigator":{"disabled":true},"exporting":{"enabled":false},"title":{"text":null},"chart":{"height":200,"style":{"fontFamily":"Roboto Flex, -apple-system, BlinkMacSystemFont, Segoe UI, Roboto, Helvetica, Arial, sans-serif, Apple Color Emoji, Segoe UI Emoji, Segoe UI Symbol","fontWeight":"400","color":"#5d5d5e"},"spacingTop":30,"spacingRight":60,"events":null},"yAxis":{"labels":{"style":{"color":"inherit"},"distance":6,"x":-6,"y":-6,"zIndex":1,"map_label_formatter":{"369":"€369","423":"€423","477":"€477","531":"€531","585":"€585"}},"plotLines":[{"color":"rgba(0,0,0,0)","value":584.03237,"label":{"className":" overflowvisible_force","align":"right","x":60,"y":-10,"text":"<div  class=\"positionrelative hoverZ3 triangleleft-bottom flexccc bgwhite shadowhard-3 border1 borderColorwhite-8 colorwhite-8 px2 lineHeight3 fontWeightsemibold fontSize10 radiismall h_pxsmall35\"> <div class=\"w_pxsmall60 flexccc\">\n  <span style=\"color:#199ca5\">High </span>\n\n  <span style=\"color:#199ca5\">€584.03</span>\n  </div></div>","useHTML":true}},{"color":"rgba(0,0,0,0)","value":512.36264588,"label":{"className":" overflowvisible_force","align":"right","x":60,"y":0,"text":"<div  class=\"positionrelative hoverZ3 triangleleft flexccc bgwhite shadowhard-3 border1 borderColorwhite-8 colorwhite-8 px2 lineHeight3 fontWeightsemibold fontSize10 radiismall h_pxsmall35\"> <div class=\"w_pxsmall60 flexccc\">\n  <span style=\"color:#828080\">Average </span>\n\n  <span style=\"color:#828080\">€512.36</span>\n  </div></div>","useHTML":true}},{"color":"rgba(0,0,0,0)","value":375.14488,"label":{"className":" overflowvisible_force","align":"right","x":60,"y":10,"text":"<div  class=\"positionrelative hoverZ3 triangleleft-top flexccc bgwhite shadowhard-3 border1 borderColorwhite-8 colorwhite-8 px2 lineHeight3 fontWeightsemibold fontSize10 radiismall h_pxsmall35\"> <div class=\"w_pxsmall60 flexccc\">\n  <span style=\"color:#912767\">Low </span>\n\n  <span style=\"color:#912767\">€375.14</span>\n  </div></div>","useHTML":true}}],"tickPositions":[369,423,477,531,585],"lineColor":"#dddddd","gridLineWidth":1,"gridLineColor":"#dddddd","lineWidth":1,"title":{"text":""}},"plotOptions":{"series":{"states":{"inactive":{"opacity":1}}},"line":{"animation":{"duration":0},"dataLabels":{"allowOverlap":true},"borderWidth":1,"marker":{"enabled":true,"fillColor":"#FFFFFF","radius":3,"lineWidth":2,"symbol":"circle","lineColor":"#828080"}}},"xAxis":{"labels":{"style":{"color":"inherit"},"rotation":0,"map_label_formatter":{"3":"Jan<br/>2025","6":"Apr<br/>2025","9":"Jul<br/>2025","12":"Oct<br/>2025","25":"Oct<br/>2026"}},"tickPositions":[3,6,9,12,25],"plotLines":[{"color":"#dddddd","width":1,"value":12},{"color":"#dddddd","width":1,"value":12}],"lineWidth":0,"gridLineWidth":1,"gridLineColor":"#dddddd","tickLength":0},"legend":{"symbolRadius":0,"symbolPadding":4,"symbolHeight":14,"borderWidth":0,"symbolWidth":14,"align":"left","verticalAlign":"bottom","enabled":false},"tooltip":{"backgroundColor":"rgba(0,0,0,0)","useHTML":true,"borderWidth":0,"borderColor":"rgba(0,0,0,0)","padding":0,"shadow":null,"headerFormat":"","footerFormat":"","pointFormat":"<div class=\"flexccc lineHeight2 bgwhite shadow2 px3 py3 radiismall fonth10_semibold\">\n                <span class=\"colorgray-3 mb4\">{point.date:%b %d ,%Y}</span>\n                <span>Analyst Consensus</span>\n                {point.info}\n          </div>\n           </div>"},"credits":{"enabled":false},"accessibility":{"description":""},"responsive":{"rules":[{"chartOptions":{"chart":{"spacing":[0,0,0,0],"margin":[30,60,40,5]},"xAxis":{"tickPositions":[3,12,25.25]},"yAxis":{"labels":{"enabled":false}},"title":{"text":null},"subtitle":{"text":null}},"condition":{"maxWidth":500}}]},"series":[{"lineWidth":2,"dashStyle":"ShortDash","name":"High","type":"line","color":"#199ca5","enableMouseTracking":false,"marker":{"enabled":false},"data":[null,null,null,null,null,null,null,null,null,null,null,null,370.35,386.7871053846154,403.2242107692308,419.6613161538462,436.0984215384616,452.535526923077,468.9726323076923,485.4097376923077,501.8468430769231,518.2839484615386,534.7210538461538,551.1581592307692,567.5952646153846,{"y":584.03237,"marker":{"fillColor":"#199ca5","lineColor":"#199ca5","enabled":true,"symbol":"circle"}}]},{"lineWidth":2,"dashStyle":"ShortDash","name":"Average","type":"line","color":"#828080","enableMouseTracking":false,"marker":{"enabled":false},"data":[null,null,null,null,null,null,null,null,null,null,null,null,370.35,381.27404968307695,392.1980993661539,403.12214904923076,414.0461987323077,424.9702484153846,435.89429809846155,446.8183477815385,457.74239746461535,468.6664471476923,479.5904968307692,490.5145465138461,501.4385961969231,{"y":512.36264588,"marker":{"fillColor":"#828080","lineColor":"#828080","enabled":true,"symbol":"circle"}}]},{"lineWidth":2,"dashStyle":"ShortDash","name":"Low","type":"line","color":"#912767","enableMouseTracking":false,"marker":{"enabled":false},"data":[null,null,null,null,null,null,null,null,null,null,null,null,370.35,370.71883692307694,371.08767384615385,371.45651076923076,371.82534769230773,372.19418461538464,372.56302153846156,372.93185846153847,373.3006953846154,373.6695323076923,374.03836923076926,374.4072061538462,374.7760430769231,{"y":375.14488,"marker":{"fillColor":"#912767","lineColor":"#912767","enabled":true,"symbol":"circle"}}]},{"type":"line","data":[{"y":439.3,"date":1727740800000,"info":" <span style=\"color:#199ca5\" class=\"mb3 mt2 fonth8_semibold\"> Strong Buy</span>\n            <div class=\"flexrcb px3 displayflex fonth9_semibold\"><span  style=\"color:#199ca5\">Buy 24,\t&nbsp; </span>\n              <span  style=\"color:#828080\">Hold 7, \t&nbsp;</span>\n              <span  style=\"color:#912767\">Sell 0</span>\n      ","marker":{"lineColor":"#199ca5","enabled":true,"symbol":"circle"}},{"y":468.25,"date":1730419200000,"info":" <span style=\"color:#199ca5\" class=\"mb3 mt2 fonth8_semibold\"> Strong Buy</span>\n            <div class=\"flexrcb px3 displayflex fonth9_semibold\"><span  style=\"color:#199ca5\">Buy 28,\t&nbsp; </span>\n              <span  style=\"color:#828080\">Hold 7, \t&nbsp;</span>\n              <span  style=\"color:#912767\">Sell 0</span>\n      ","marker":{"lineColor":"#199ca5","enabled":true,"symbol":"circle"}},{"y":517.3,"date":1733011200000,"info":" <span style=\"color:#199ca5\" class=\"mb3 mt2 fonth8_semibold\"> Strong Buy</span>\n            <div class=\"flexrcb px3 displayflex fonth9_semibold\"><span  style=\"color:#199ca5\">Buy 39,\t&nbsp; </span>\n              <span  style=\"color:#828080\">Hold 8, \t&nbsp;</span>\n              <span  style=\"color:#912767\">Sell 0</span>\n      ","marker":{"lineColor":"#199ca5","enabled":true,"symbol":"circle"}},{"y":512.7,"date":1735689600000,"info":" <span style=\"color:#199ca5\" class=\"mb3 mt2 fonth8_semibold\"> Strong Buy</span>\n            <div class=\"flexrcb px3 displayflex fonth9_semibold\"><span  style=\"color:#199ca5\">Buy 54,\t&nbsp; </span>\n              <span  style=\"color:#828080\">Hold 9, \t&nbsp;</span>\n              <span  style=\"color:#912767\">Sell 0</span>\n      ","marker":{"lineColor":"#199ca5","enabled":true,"symbol":"circle"}},{"y":562.2,"date":1738368000000,"info":" <span style=\"color:#199ca5\" class=\"mb3 mt2 fonth8_semibold\"> Strong Buy</span>\n            <div class=\"flexrcb px3 displayflex fonth9_semibold\"><span  style=\"color:#199ca5\">Buy 49,\t&nbsp; </span>\n              <span  style=\"color:#828080\">Hold 9, \t&nbsp;</span>\n              <span  style=\"color:#912767\">Sell 0</span>\n      ","marker":{"lineColor":"#199ca5","enabled":true,"symbol":"circle"}},{"y":538,"date":1740787200000,"info":" <span style=\"color:#199ca5\" class=\"mb3 mt2 fonth8_semibold\"> Strong Buy</span>\n            <div class=\"flexrcb px3 displayflex fonth9_semibold\"><span  style=\"color:#199ca5\">Buy 49,\t&nbsp; </span>\n              <span  style=\"color:#828080\">Hold 9, \t&nbsp;</span>\n              <span  style=\"color:#912767\">Sell 0</span>\n      ","marker":{"lineColor":"#199ca5","enabled":true,"symbol":"circle"}},{"y":456.45,"date":1743465600000,"info":" <span style=\"color:#199ca5\" class=\"mb3 mt2 fonth8_semibold\"> Strong Buy</span>\n            <div class=\"flexrcb px3 displayflex fonth9_semibold\"><span  style=\"color:#199ca5\">Buy 38,\t&nbsp; </span>\n              <span  style=\"color:#828080\">Hold 3, \t&nbsp;</span>\n              <span  style=\"color:#912767\">Sell 0</span>\n      ","marker":{"lineColor":"#199ca5","enabled":true,"symbol":"circle"}},{"y":449.95,"date":1746057600000,"info":" <span style=\"color:#199ca5\" class=\"mb3 mt2 fonth8_semibold\"> Strong Buy</span>\n            <div class=\"flexrcb px3 displayflex fonth9_semibold\"><span  style=\"color:#199ca5\">Buy 40,\t&nbsp; </span>\n              <span  style=\"color:#828080\">Hold 4, \t&nbsp;</span>\n              <span  style=\"color:#912767\">Sell 0</span>\n      ","marker":{"lineColor":"#199ca5","enabled":true,"symbol":"circle"}},{"y":480.7,"date":1748736000000,"info":" <span style=\"color:#199ca5\" class=\"mb3 mt2 fonth8_semibold\"> Strong Buy</span>\n            <div class=\"flexrcb px3 displayflex fonth9_semibold\"><span  style=\"color:#199ca5\">Buy 37,\t&nbsp; </span>\n              <span  style=\"color:#828080\">Hold 3, \t&nbsp;</span>\n              <span  style=\"color:#912767\">Sell 1</span>\n      ","marker":{"lineColor":"#199ca5","enabled":true,"symbol":"circle"}},{"y":455.95,"date":1751328000000,"info":" <span style=\"color:#199ca5\" class=\"mb3 mt2 fonth8_semibold\"> Strong Buy</span>\n            <div class=\"flexrcb px3 displayflex fonth9_semibold\"><span  style=\"color:#199ca5\">Buy 40,\t&nbsp; </span>\n              <span  style=\"color:#828080\">Hold 6, \t&nbsp;</span>\n              <span  style=\"color:#912767\">Sell 1</span>\n      ","marker":{"lineColor":"#199ca5","enabled":true,"symbol":"circle"}},{"y":418.05,"date":1754006400000,"info":" <span style=\"color:#199ca5\" class=\"mb3 mt2 fonth8_semibold\"> Strong Buy</span>\n            <div class=\"flexrcb px3 displayflex fonth9_semibold\"><span  style=\"color:#199ca5\">Buy 39,\t&nbsp; </span>\n              <span  style=\"color:#828080\">Hold 5, \t&nbsp;</span>\n              <span  style=\"color:#912767\">Sell 2</span>\n      ","marker":{"lineColor":"#199ca5","enabled":true,"symbol":"circle"}},{"y":404.2,"date":1756684800000,"info":" <span style=\"color:#199ca5\" class=\"mb3 mt2 fonth8_semibold\"> Strong Buy</span>\n            <div class=\"flexrcb px3 displayflex fonth9_semibold\"><span  style=\"color:#199ca5\">Buy 37,\t&nbsp; </span>\n              <span  style=\"color:#828080\">Hold 5, \t&nbsp;</span>\n              <span  style=\"color:#912767\">Sell 1</span>\n      ","marker":{"lineColor":"#199ca5","enabled":true,"symbol":"circle"}},{"y":370.35,"date":1759276800000,"info":" <span style=\"color:#199ca5\" class=\"mb3 mt2 fonth8_semibold\"> Strong Buy</span>\n            <div class=\"flexrcb px3 displayflex fonth9_semibold\"><span  style=\"color:#199ca5\">Buy 13,\t&nbsp; </span>\n              <span  style=\"color:#828080\">Hold 0, \t&nbsp;</span>\n              <span  style=\"color:#912767\">Sell 1</span>\n      ","marker":{"fillColor":"black","lineColor":"black","enabled":true,"symbol":"circle"}},null,null,null,null,null,null,null,null,null,null,null,null],"color":"#0666a7"}]}

Highest Price Target€584.03

Average Price Target€512.36

Lowest Price Target€375.14

The highest, average, and lowest price target of all analysts. Click on ‘Top Analysts’ to focus on the best performers.

Detailed List of Analyst Forecasts

Ryan Zimmerman

BTIG

€486.84

Buy

26.11%

Upside

Reiterated

10/01/25

Analysts Offer Insights on Healthcare Companies: Intuitive Surgical (NASDAQ: ISRG) and Dexcom (NASDAQ: DXCM)

Travis Steed

Bank of America Securities

€554.19

Buy

43.55%

Upside

Reiterated

09/29/25

Intuitive Surgical's Strategic Innovations and Market Position Drive Buy Rating

Patrick Wood

Morgan Stanley

€554.19

Buy

43.55%

Upside

Reiterated

09/29/25

Intuitive Surgical's Growth Potential in Endoluminal Robotics: A Buy Rating Analysis

Lee Hambright

Bernstein

€584.03

Buy

51.28%

Upside

Assigned

09/26/25

Wall Street Analysts Are Bullish on Top Healthcare Picks

Brandon Vazquez

William Blair

―

Buy

―

Reiterated

09/15/25

Analysts Offer Insights on Healthcare Companies: Intuitive Surgical (NASDAQ: ISRG) and Milestone Scientific (NYSE MKT: MLSS)

Adam Maeder

Piper Sandler

€507.3

Buy

31.41%

Upside

Reiterated

08/22/25

Piper Sandler Sticks to Its Buy Rating for Intuitive Surgical (ISRG)

Imron Zafar

Deutsche Bank

€375.14

Sell

-2.82%

Downside

Reiterated

08/22/25

Deutsche sees remanufactured instrument risk for Intuitive SurgicalDeutsche sees remanufactured instrument risk for Intuitive Surgical

Mike Kratky

Leerink Partners

€505.59

Buy

30.97%

Upside

Reiterated

08/19/25

Intuitive Surgical selloff brings attractive opportunity, says LeerinkIntuitive Surgical selloff brings attractive opportunity, says Leerink

Shagun Singh Chadha

RBC Capital

€524.35

Buy

35.82%

Upside

Reiterated

08/18/25

Intuitive Surgical (ISRG) Gets a Buy from RBC Capital

Richard Newitter

Truist Financial

€503.04→€511.56

Buy

32.51%

Upside

Reiterated

07/23/25

Analysts' Opinions Are Mixed on These Healthcare Stocks: Intuitive Surgical (NASDAQ: ISRG), Quest Diagnostics (NYSE: DGX) and Ultragenyx Pharmaceutical (NASDAQ: RARE)

Jayson Bedford

Raymond James

€504.74

Buy

30.74%

Upside

Reiterated

07/23/25

Intuitive Surgical (ISRG) Receives a Buy from Raymond James

Joanne Wuensch

Citi

―

Buy

―

Reiterated

07/23/25

We reiterate our Buy on ISRG.

Matt Miksic

Barclays

€541.4

Buy

40.24%

Upside

Reiterated

07/23/25

Barclays Sticks to Their Buy Rating for Intuitive Surgical (ISRG)

Anthony Petrone

Mizuho Securities

―

Hold

―

Reiterated

07/23/25

Mizuho Securities Keeps Their Hold Rating on Intuitive Surgical (ISRG)

David Rescott

Robert W. Baird

€503.04→€511.56

Buy

32.51%

Upside

Reiterated

07/23/25

Robert W. Baird Keeps Their Buy Rating on Intuitive Surgical (ISRG)

Ranks

Any

Analyst Rating

Any

Upside/ Downside

Any

Action

Any

Ryan Zimmerman

BTIG

€486.84

Buy

26.11%

Upside

Reiterated

10/01/25

Analysts Offer Insights on Healthcare Companies: Intuitive Surgical (NASDAQ: ISRG) and Dexcom (NASDAQ: DXCM)

Travis Steed

Bank of America Securities

€554.19

Buy

43.55%

Upside

Reiterated

09/29/25

Intuitive Surgical's Strategic Innovations and Market Position Drive Buy Rating

Patrick Wood

Morgan Stanley

€554.19

Buy

43.55%

Upside

Reiterated

09/29/25

Intuitive Surgical's Growth Potential in Endoluminal Robotics: A Buy Rating Analysis

Lee Hambright

Bernstein

€584.03

Buy

51.28%

Upside

Assigned

09/26/25

Wall Street Analysts Are Bullish on Top Healthcare Picks

Brandon Vazquez

William Blair

―

Buy

―

Reiterated

09/15/25

Analysts Offer Insights on Healthcare Companies: Intuitive Surgical (NASDAQ: ISRG) and Milestone Scientific (NYSE MKT: MLSS)

Adam Maeder

Piper Sandler

€507.3

Buy

31.41%

Upside

Reiterated

08/22/25

Piper Sandler Sticks to Its Buy Rating for Intuitive Surgical (ISRG)

Imron Zafar

Deutsche Bank

€375.14

Sell

-2.82%

Downside

Reiterated

08/22/25

Deutsche sees remanufactured instrument risk for Intuitive SurgicalDeutsche sees remanufactured instrument risk for Intuitive Surgical

Mike Kratky

Leerink Partners

€505.59

Buy

30.97%

Upside

Reiterated

08/19/25

Intuitive Surgical selloff brings attractive opportunity, says LeerinkIntuitive Surgical selloff brings attractive opportunity, says Leerink

Shagun Singh Chadha

RBC Capital

€524.35

Buy

35.82%

Upside

Reiterated

08/18/25

Intuitive Surgical (ISRG) Gets a Buy from RBC Capital

Richard Newitter

Truist Financial

€503.04→€511.56

Buy

32.51%

Upside

Reiterated

07/23/25

Analysts' Opinions Are Mixed on These Healthcare Stocks: Intuitive Surgical (NASDAQ: ISRG), Quest Diagnostics (NYSE: DGX) and Ultragenyx Pharmaceutical (NASDAQ: RARE)

Jayson Bedford

Raymond James

€504.74

Buy

30.74%

Upside

Reiterated

07/23/25

Intuitive Surgical (ISRG) Receives a Buy from Raymond James

Joanne Wuensch

Citi

―

Buy

―

Reiterated

07/23/25

We reiterate our Buy on ISRG.

Matt Miksic

Barclays

€541.4

Buy

40.24%

Upside

Reiterated

07/23/25

Barclays Sticks to Their Buy Rating for Intuitive Surgical (ISRG)

Anthony Petrone

Mizuho Securities

―

Hold

―

Reiterated

07/23/25

Mizuho Securities Keeps Their Hold Rating on Intuitive Surgical (ISRG)

David Rescott

Robert W. Baird

€503.04→€511.56

Buy

32.51%

Upside

Reiterated

07/23/25

Robert W. Baird Keeps Their Buy Rating on Intuitive Surgical (ISRG)

Stocks with the Highest Top Analyst Consensus in the Healthcare Sector

xxx

Find stocks in the Healthcare sector that are highly recommended by Top Performing Analysts.

Best Analysts Covering Intuitive Surgical

1 Month

xxx

Success Rate

15/23 ratings generated profit

Average Return

+3.27%

reiterated a xxx

rating 2 months ago

Copying xxxxxxxxxxxxxxxxxx

trades and holding each position for 1 Month would result in 65.22% of your transactions generating a profit, with an average return of +3.27% per trade.

3 Months

xxx

Success Rate

24/32 ratings generated profit

Average Return

+7.88%

reiterated a xxx

rating 3 months ago

Copying xxxxxxxxxxxxxxxxxx

trades and holding each position for 3 Months would result in 75.00% of your transactions generating a profit, with an average return of +7.88% per trade.

1 Year

Richard NewitterTruist Financial

Success Rate

26/34 ratings generated profit

Average Return

+25.78%

reiterated a buy rating 3 months ago

Copying Richard Newitter's trades and holding each position for 1 Year would result in 76.47% of your transactions generating a profit, with an average return of +25.78% per trade.

2 Years

xxx

Success Rate

27/34 ratings generated profit

Average Return

+57.99%

reiterated a xxx

rating 3 months ago

Copying xxxxxxxxxxxxxxxxxx

trades and holding each position for 2 Years would result in 79.41% of your transactions generating a profit, with an average return of +57.99% per trade.

The Best Analyst Covering tool allows you to follow the analysts who have the best success rates and average returns on a specific stock. Only analysts that gave a Buy or Sell rating on the stock in the past 12 months are eligible for inclusion in this tool. Follow the analysts of your choice to receive real-time updates when they publish a new rating.

1ISRG Analyst Recommendation Trends

Rating

Jun 25

Jul 25

Aug 25

Sep 25

Oct 25

Strong Buy

Buy

Hold

Sell

Strong Sell

total

In the current month, 1ISRG has received 13 Buy Ratings, 0 Hold Ratings, and 1 Sell Ratings. 1ISRG average Analyst price target in the past 3 months is 512.36.

Each month's total comprises the sum of three months' worth of ratings.

1ISRG Financial Forecast

1ISRG Earnings Forecast

Next quarter’s earnings estimate for 1ISRG is €1.70 with a range of €1.58 to €1.83. The previous quarter’s EPS was €1.87. 1ISRG beat its EPS estimate 0.00% of the time in the past 12 months, while its overall industry beat the EPS estimate 57.09% of the time in the same period. In the last calendar year 1ISRG has Preformed in-line its overall industry.

1ISRG Sales Forecast

Next quarter’s sales forecast for 1ISRG is €2.05B with a range of €2.00B to €2.10B. The previous quarter’s sales results were €2.08B. 1ISRG beat its sales estimates 0.00% of the time in past 12 months, while its overall industry beat sales estimates 47.55% of the time in the same period. In the last calendar year 1ISRG has Preformed in-line its overall industry.

1ISRG Stock Forecast FAQ

What is IT:1ISRG’s average 12-month price target, according to analysts?

Based on analyst ratings, Intuitive Surgical’s 12-month average price target is 512.36.

What is IT:1ISRG’s upside potential, based on the analysts’ average price target?

Intuitive Surgical has 32.72% upside potential, based on the analysts’ average price target.

Can I see which stocks the top-ranking analysts are rating?

Yes, go to the Analysts’ Top Stocks tool to see stocks with a Strong Buy or Strong Sell analyst rating consensus, according to the top performers.

How can I follow the stock ratings of top Wall Street analysts?

Head over to our Expert Center to see a list of the top 100 Wall Street analysts and follow the analysts of your choice. Visit their profiles for more details about their stock ratings and see how they perform on a stock-by-stock basis.

Is Intuitive Surgical a Buy, Sell or Hold?

Intuitive Surgical has a consensus rating of Moderate Buy, which is based on 16 buy ratings, 4 hold ratings and 1 sell ratings.

What is Intuitive Surgical’s share price target?

The average share price target for Intuitive Surgical is 512.36. This is based on 21 Wall Streets Analysts 12-month price targets, issued in the past 3 months.
The highest analyst share price target is €584.03 ,and the lowest forecast is €375.14. The average share price target represents 32.72% Increase from the current price of €386.05.

What do analysts say about Intuitive Surgical?

Intuitive Surgical’s analyst rating consensus is a Moderate Buy. This is based on the ratings of 21 Wall Streets Analysts.

How can I buy shares of Intuitive Surgical?

To buy shares of IT:1ISRG, you can open a brokerage account. See exclusive account opening deals on our Best Online Brokers page.

Become an Expert with TipRanks Premium

What am I Missing?

Make informed decisions based on Top Analysts' activity

Know what industry insiders are buying

Get actionable alerts from top Wall Street Analysts

Find out before anyone else which stock is going to shoot up

Get powerful stock screeners & detailed portfolio analysis

Subscribe Now See Plans & Pricing

Intuitive Surgical (1ISRG) Stock Forecast & Price Target

1ISRG Analyst Ratings

1ISRG Stock 12 Month Forecast

Average Price Target

Detailed List of Analyst Forecasts​

Best Analysts Covering Intuitive Surgical

1ISRG Analyst Recommendation Trends

1ISRG Financial Forecast

1ISRG Earnings Forecast

1ISRG Sales Forecast

1ISRG Stock Forecast FAQ

Become an Expert with TipRanks Premium

Detailed List of Analyst Forecasts